SCHEMBL23225609

SCHEMBL23225609

CC(C)OCCN1c2cc[nH]c2C(=O)NC1SI

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.37
▸ MPO P05164 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23225699 0.81 OPRM1 (0.39) OPRM1MPO
SCHEMBL29879452 0.80 OPRM1 (0.37) OPRM1MPO
SCHEMBL28849738 0.78 OPRM1 (0.37) OPRM1MPO
SCHEMBL29879210 0.78 OPRM1 (0.37) OPRM1MPO
SCHEMBL28957065 0.73 OPRM1 (0.33) OPRM1MPO
SCHEMBL23225608 0.72 OPRM1 (0.40) OPRM1MPO
SCHEMBL23225606 0.65 OPRM1 (0.36) OPRM1MPO
SCHEMBL29211274 0.63 OPRM1 (0.31) OPRM1MPO
SCHEMBL29211243 0.62 HSP90AA1 (0.32) OPRM1MPOHSP90AA1
SCHEMBL29211266 0.62 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072140-A1 PRODRUGS OF MYELOPEROXIDASE INHIBITORS BIOHAVEN THERAPEUTICS LTD. (US) 2021-04-15 — — WO disclosed
Send feedback